Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Suvorexant for Restless Legs Syndrome
NCT03755310Phase 2Unknown
- Start
- Feb 2019
- Primary completion
- Mar 2020
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of suvorexant in restless legs syndrome (RLS). Status: unknown.
02
Drugs
suvorexant
03
Conditions
restless legs syndrome (RLS)
Beyond the preview
Go deeper on NCT03755310.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03755310.